75 results

• Eli Lilly Warns About Potential Health Risks From Mounjaro, Zepbound Counterfeit Versions

  March 8, 2024

  Irvin Jackson

  Eli Lilly warns that compounded and fake versions of Mounjaro and Zepbound carry potential health risks, and warn that even the legal versions of the drugs should not be used for cosmetic weight loss.

• Nearly 3,000 Ozempic Poisoning Cases Reported to Poison Control Centers in 2023

  December 14, 2023

  Irvin Jackson

  Poison centers nationwide have seen a 15-fold increase in Ozempic and Wegovy poisoning reports since 2019, with 3,000 filed this year alone.

• FDA Warns of Mental Health Side Effects Linked to Ketamine Use

  October 16, 2023

  Katherine McDaniel

  The FDA is warning patients that using compounded ketamine may increase the risk of mental disorders.

• FDA Warns Against Use of Compounded Versions of Ozempic, Wegovy

  June 1, 2023

  Irvin Jackson

  The FDA is warning that some compounding pharmacies are using unapproved versions of the active ingredients of Ozempic and Wegovy to create substitutes of the diabetes and weight loss drugs due to a current shortage.

• FDA Issues Guidance on Preparing Beta-Lactam Antibiotics, Which are Linked to Severe Allergic Reactions

  November 28, 2022

  Irvin Jackson

  The FDA has issued guidance on compounding Beta-lactam safely due to an antibiotics shortage, focused on preventing cross-contamination which could result in severe allergic reactions

• FDA Finalizes Guidance On Unsanitary Conditions At Compounding Pharmacies

  November 10, 2020

  Martha Garcia

  New FDA guidance seeks to lay out best practices for compounding pharmacies to meet sanitary and cleanliness standards, and prevent potential outbreaks or medication contamination.

• Lingering Problems With Sterile Compounded Drug Manufacturing Found in ISMP Survey

  October 29, 2020

  Martha Garcia

  A new survey finds many compounding pharmacies still make dispensing errors despite stringent improvements and requirements put in place over the last several years.

• ISMP Warns Of Potential Remdesivir, Propofol And Vincristine Compounding Errors

  August 25, 2020

  Irvin Jackson

  Labeling problems and confusion has led to a number of medication errors linked to three drugs, whose overdoses or incorrect application could lead to serious injuries and death, according to a new ISMP report.

• Reporting of Compounded Drug Problems Needs Improvement: FDA

  September 12, 2019

  Martha Garcia

  The FDA is working on new policies and actions to shore up the safety of compounding pharmacies, after discovering some have avoided reporting adverse events as required by law.

• FDA Warns About Risk of Confusion, Dosing Errors with Compounded Injectable Drugs

  October 1, 2018

  Martha Garcia

  The FDA warns that label differences between compounding pharmacies and traditional drug manufacturers may lead to dosing errors with injectable drugs.